# Aeris Capital: portfolio, investments and team > Aeris Capital is a growth equity based in Switzerland. 33 investments on record, latest May 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/aeris-capital (Millionrounds; every figure on the page links to its filing or article) Switzerland · [Investor](https://millionrounds.com/investors) # Aeris Capital Last cheque observed May 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Growth equity Website unconfirmed Series C Series D Series A E-Commerce Internet Cheques on record **0%** of best year **0** **cheques in 12 months**, 33 on record Since the last cheque **4176** days **00** hrs **00** min **00** sec Median round **$18M** Rounds led **0 of 33** Sole investor **4 rounds** Exits **3 from the portfolio** Mostly in **United States, 79%** Pitch Aeris Capital ## Aeris Capital highlights - 01 33 rounds on record - 02 Mostly Series C and Series D: 48% of its rounds - 03 Sole investor in 4 rounds, median $6.0M - 04 3 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** E-Commerce Internet - **Based in:** Zurich, Switzerland - **Cold pitches:** Not stated A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=aeris-capital). ## The record Every round we can evidence, newest first **33 appearances** - **2015** 1 round - **May** **[Jiff](https://millionrounds.com/company/jiff)** Series C · US **$23M** With 4 others - **2014** 5 rounds - **Nov** **[Curetis](https://millionrounds.com/company/curetis)** Series B · DE **$18M** With 6 others - **Nov** **[Butterfly Network](https://millionrounds.com/company/butterfly-network)** Growth · US · Firms' own news pages **$100M** With 1 other - **Sept** **[Jiff](https://millionrounds.com/company/jiff)** Series B · US **$18M** With 2 others - **Sept** **[Affimed Therapeutics](https://millionrounds.com/company/affimed-therapeutics)** Series E · DE **$16M** With 2 others - **Aug** **[Smaato](https://millionrounds.com/company/smaato)** Series E · US **$25M** With 2 others - **2013** 4 rounds - **Dec** **[Invincea](https://millionrounds.com/company/invincea)** Series C · US **$16M** With 4 others - **Sept** **[GenomeDx Biosciences](https://millionrounds.com/company/genomedx-biosciences)** Series B · CA · socaltech.com **Undisclosed** With 3 others - **Jan** **[Solstice Biologics](https://millionrounds.com/company/solstice-biologics)** Series A · US · finsmes.com **$18M** With 1 other - **Jan** **[Crescendo Bioscience](https://millionrounds.com/company/crescendo-bioscience)** Series D · US · pevc.dowjones.com **$28M** With 4 others - **2012** 5 rounds - **Dec** **[Solstice Biologics](https://millionrounds.com/company/solstice-biologics)** Growth · US · sec.gov **$7.5M** With 1 other - **Jun** **[Nanosolar](https://millionrounds.com/company/nanosolar)** Growth · US · forbes.com **$70M** With 2 others - **Mar** **[Jiff](https://millionrounds.com/company/jiff)** Series A · US · freshnews.com **$7.5M** With 2 others - **Jan** **[GenomeDx Biosciences](https://millionrounds.com/company/genomedx-biosciences)** Series A · CA · finsmes.com **Undisclosed** With 1 other - **Jan** **[Livescribe](https://millionrounds.com/company/livescribe)** Venture · US **$3.3M** With 6 others - **2011** 6 rounds - **Sept** **[Crescendo Bioscience](https://millionrounds.com/company/crescendo-bioscience)** Series C · US · crescendobio.com **$56M** With 2 others - **Jul** **[SynapSense](https://millionrounds.com/company/synapsense)** Series C · US · techcrunch.com **$16M** With 6 others - **Jun** **[Smaato](https://millionrounds.com/company/smaato)** Series C · US **$3.0M** With 1 other - **Jun** **[Smaato](https://millionrounds.com/company/smaato)** Series D · US **$3.0M** With 1 other - **Jan** **[Smaato](https://millionrounds.com/company/smaato)** Series C · US · smaato.com **$7.0M** With 1 other - **Jan** **[Coda Automotive](https://millionrounds.com/company/coda-automotive)** Series D · US · techcrunch.com **$76M** With 3 others - **2010** 4 rounds - **Sept** **[Livescribe](https://millionrounds.com/company/livescribe)** Series C · US · livescribe.com **$39M** With 8 others - **May** **[Coda Automotive](https://millionrounds.com/company/coda-automotive)** Series C · US · prnewswire.com **$58M** With 3 others - **Apr** **[Affimed Therapeutics](https://millionrounds.com/company/affimed-therapeutics)** Series C · DE · fiercebiotech.com **$27M** With 2 others - **Feb** **[Mode Media](https://millionrounds.com/company/mode-media)** Series E · US · techcrunch.com **$50M** With 1 other - **2009** 6 rounds - **Dec** **[Curetis](https://millionrounds.com/company/curetis)** Series A · DE · curetis.com **$28M** With 3 others - **Dec** **[Smaato](https://millionrounds.com/company/smaato)** Series B · US · digital.venturebeat.com **$4.5M** Sole investor - **Nov** **[Tethys BioScience](https://millionrounds.com/company/tethys-bioscience)** Series D · US · deals.venturebeat.com **$25M** With 4 others - **Oct** **[Adamas Pharmaceuticals](https://millionrounds.com/company/adamas-pharmaceuticals)** Series D · US · onbiovc.com **$40M** With 3 others - **Aug** **[ConforMIS](https://millionrounds.com/company/conformis)** Series D · US · onbiovc.com **$50M** Sole investor - **Mar** **[Livescribe](https://millionrounds.com/company/livescribe)** Series B · US · dealipedia.com **$7.5M** Sole investor - **2008** 2 rounds - **Mar** **[mobileo](https://millionrounds.com/company/mobileo)** Seed · DE **$3.8M** Sole investor - **Jan** **[Smaato](https://millionrounds.com/company/smaato)** Series A · US · venturebeat.com **$3.6M** With 1 other An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team We hold **4** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **3 in all** **[Livescribe](https://millionrounds.com/company/livescribe)** Bought by Anoto Group **$15M** Nov 2015 **[SynapSense](https://millionrounds.com/company/synapsense)** Bought by Panduit **Undisclosed** May 2014 **[Crescendo Bioscience](https://millionrounds.com/company/crescendo-bioscience)** Bought by [Myriad Genetics](https://millionrounds.com/fund/myriad-genetics) **$270M** Feb 2014 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series C Series D Series A Median round joined **$18M** the round, not its cheque Alone, median **$6.0M** Led 0 of 33 rounds **0%** - **Sole investor:** 4 rounds - **Last cheque:** May 2015 - **Exits:** 3 from the portfolio Rounds by stage said on their site - Series C *9* - Series D *6* - Series A *5* - Series B *5* - Growth *3* - Series E *3* Cheques by year Led Joined 2008 2015 Often in the room with - [Mohr Davidow Ventures](https://millionrounds.com/fund/mohr-davidow-ventures) 5 - [Aberdare Ventures](https://millionrounds.com/fund/aberdare-ventures) 3 - [EDBI](https://millionrounds.com/fund/edbi) 3 - [EQT life science](https://millionrounds.com/fund/lsp-bioventures) 3 - [Kleiner Perkins Caufield & Byers](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers) 3 - [Baird Capital](https://millionrounds.com/fund/baird-capital) 2 **Pitching Aeris Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Aeris Capital. A count of rooms they were both in, not a relationship either has claimed. [**Mohr Davidow Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/mohr-davidow-ventures)[**Aberdare Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/aberdare-ventures)[**EDBI** VC firm **3** rounds together](https://millionrounds.com/fund/edbi)[**EQT life science** Private equity **3** rounds together](https://millionrounds.com/fund/lsp-bioventures)[**Kleiner Perkins Caufield & Byers** VC firm **3** rounds together](https://millionrounds.com/fund/kleiner-perkins-caufield-and-byers)[**Baird Capital** Wealth manager **2** rounds together](https://millionrounds.com/fund/baird-capital)[**BioMedInvest** Growth equity **2** rounds together](https://millionrounds.com/fund/biomedinvest)[**BioMedPartners** Private equity **2** rounds together](https://millionrounds.com/fund/biomedpartners)[**CD-Venture** VC firm **2** rounds together](https://millionrounds.com/fund/cd-venture)[**Crosslink Capital** VC firm **2** rounds together](https://millionrounds.com/fund/crosslink-capital)[**EDB Investments** Growth equity **2** rounds together](https://millionrounds.com/fund/edb-investments)[**Keating Capital** Growth equity **2** rounds together](https://millionrounds.com/fund/keating-capital) ## Quick answers about Aeris Capital ### What does Aeris Capital invest in? Aeris Capital invests most often at Series C and Series D (48% of the rounds on record), in sectors such as E-Commerce and Internet. ### How active is Aeris Capital? 33 investments on record, 0 of them in the last 12 months. The most recent was in May 2015. ### How big are Aeris Capital's cheques? The median round it joins is $18M. ### Does Aeris Capital lead rounds? Rarely, if at all: none of its 33 investments on record names it as the lead. ### Where does Aeris Capital invest? Most of the companies it backs are in the United States (79%), Germany (15%) and Canada (6%). ### Is Aeris Capital investing now? No investments in the last 12 months; the latest was in May 2015. ### Who does Aeris Capital invest alongside? Most often Mohr Davidow Ventures (5 rounds together), Aberdare Ventures (3 rounds together) and EDBI (3 rounds together). ### What kind of investor is Aeris Capital? Aeris Capital is a growth equity firm based in Zurich, Switzerland. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=aeris-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=aeris-capital)